Login

Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Jan 5, 2023
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
ASSETS
Current Assets:
Cash
Deferred offering costs
Prepaid expenses
Total Current Assets
Cash and marketable securities held in Trust Account
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities:
Accounts payable and accrued expenses
Accrued offering costs
Convertible promissory note – related party, at fair value
Deferred underwriting fee payable
Warrant liabilities
Income taxes payable
Total Current Liabilities
Non-current Liabilities:
Convertible promissory note – related party, at fair value
Deferred underwriting fee payable
Warrant liabilities
Total Liabilities
Class A common stock subject to possible redemption; 4,208,579 shares at redemption value at March 31, 2023 and December 31, 2022, respectively
Common Class A
Total class A common stock subject to possible redemption; 4,208,579 shares at redemption value at March 31, 2023 and December 31, 2022, respectively
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Common stock value
Common Class A
Common Class B
Additional paid-in capital
Accumulated deficit
Common Class A
Common Class B
Total Stockholders' Deficit
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support